{"SPADE_N_06299": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_06299", "Peptide Name": "KW5", "Source": "Bovine lactoferrin (Lf-B)", "Family": "", "Gene": "Not found", "Sequence": "KAAKKAAKAAKKAAKAAKKAA", "Sequence Length": 21, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:FEMX-I (IC50=30±3 µM); HT-29 (IC50=55±14 µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C90H170N30O22", "Mass": 2024.5, "PI": 10.9, "Net Charge": 9, "Hydrophobicity": -0.64, "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min", "Comments": "Peptides induce lysis of cancer cells through interactions with the plasma membrane", "Literature": [{"Title": "The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells", "Pubmed ID": "19527490", "Reference": "BMC Cancer. 2009 Jun 15;9183.", "Author": "Fadnes B, Rekdal O, Uhlin-Hansen L.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=19527490"}], "Frequent Amino Acids": "AK", "Absent Amino Acids": "CDEFGHILMNOPQRSTUVWY", "Basic Residues": 9, "Acidic Residues": 0, "Hydrophobic Residues": 12, "Polar Residues": 21, "Positive Residues": 9, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_04037", "Similarity": 1.0, "Sequence": "KAAHVG"}, {"SPADE_ID": "SPADE_UN_01189", "Similarity": 1.0, "Sequence": "KAAKKAAKKAAKKAAKKAAKKAAKKAAK"}, {"SPADE_ID": "SPADE_UN_15903", "Similarity": 1.0, "Sequence": "KAAK"}]}}}